NUTX operates 27 "micro-hospitals" within 12 US states. Analysts see an excellent runway of opportunities, expecting annual EPS growth in excess of 30% over the next five years. It trades at 8x earnings, 3.5x book and supports a robust 63% ROE. Cash reserves are growing, while debt is retired. We recommend setting a stop-loss at $126, looking to achieve $204 - upside potential of 28%. Yield 0%
Our PAST TOP PICK with NUTX has triggered its stop at $126. To remain disciplined, we recommend covering the position at this time.